-
June 26, 2012
The NHS in England met its target of delivering £5.8 billion-worth of Quality, Innovation, Productivity and Prevention (QIPP) efficiency savings during 2011/12, writes Service chief executive Sir David Nicholson, in his latest annual report.
Full story
-
May 03, 2012
The Cancer Drugs Fund for England was launched in April 2011 as a short-term solution to drug access issues until value-based pricing begins in 2014, but withdrawing it after that date "could prove quite tricky" for Ministers, a leading expert has warned.
Full story
-
January 03, 2012
Half-way through 2011-12, the first year of its QIPP programme, the NHS in England had released £2.5 billion in QIPP savings - around 42% of the forecast annual total.
Full story
-
October 04, 2011
The NHS in England performed strongly in the first quarter of this financial year, and SHAs and PCTs are forecasting a surplus for 2011-12 of £1,165 million, says the Service's latest progress report.
Full story
-
January 27, 2011
Patient access to drugs approved by the National Institute for Health and Clinical Excellence (NICE) continues to vary widely at Primary Care Trust (PCT) level, new research shows.
Full story
-
October 14, 2010
The great majority of NHS trusts and Primary Care Trusts (PCTs) are managing their money well, the Audit Commission has reported.
Full story
-
October 12, 2010
The government should reconsider the speed and scale of its proposed health reforms if they are to deliver benefits to patients and improve NHS performance, according to The King’s Fund.
Full story